NMPA Key Laboratory for Research and Evaluation of Innovative Drug, officially designated by the National Medical Products Administration (NMPA), is established under the Tsinghua University's School of Pharmaceutical Sciences and the Global Health Drug Discovery Institute (GHDDI). The laboratory will focus on addressing strategic needs in pharmaceutical innovation and regulatory science by conducting original research and technological breakthroughs in drug regulatory technology. It aims to resolve fundamental, critical, cutting-edge, and strategic technological challenges in the field, thereby playing a vital role in advancing the scientific, legal, international, and modern development of China's pharmaceutical regulatory system.